1 | FRMD5, NEDEMA, ROCK1
|
| De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement
|
| Lu S, Ma M, Mao X, Bacino CA, Jankovic J, Sutton VR, Bartley JA, Wang X, Rosenfeld JA, Beleza-Meireles A, Chauhan J, Pan X, Li M, Liu P, Prescott K, Amin S, Davies G, Wangler MF, Dai Y, Bellen HJ.
|
| Am J Hum Genet. Oct 6;109(10):1932-1943. doi: 10.1016/j.ajhg.2022.09.005. 2022
|
2 | FRMD5, TCF7L2
|
| Identification of FERM domain-containing protein 5 as a novel target of β-catenin/TCF7L2 complex
|
| Zhu C, Yamaguchi K, Ohsugi T, Terakado Y, Noguchi R, Ikenoue T, Furukawa Y.
|
| Cancer Sci. Apr;108(4):612-619. doi: 10.1111/cas.13174. Epub 2017 Apr 20. 2017
|
3 | FRMD5, ROCK1
|
| FERM domain-containing protein FRMD5 regulates cell motility via binding to integrin β5 subunit and ROCK1
|
| Hu J, Niu M, Li X, Lu D, Cui J, Xu W, Li G, Zhan J, Zhang H.
|
| FEBS Lett. Nov 28;588(23):4348-56. doi: 10.1016/j.febslet.2014.10.012. Epub 2014 Oct 18 2014
|
4 | CTNND1, FRMD5
|
| FERM-containing protein FRMD5 is a p120-catenin interacting protein that regulates tumor progression
|
| Wang T, Pei X, Zhan J, Hu J, Yu Y, Zhang H.
|
| FEBS Lett. Sep 21;586(19):3044-50. doi: 10.1016/j.febslet.2012.07.019. Epub 2012 Jul 27. 2012
|